Corrigendum: Current Diagnosis and Management of Immune Related Adverse Events (irAEs) Induced by Immune Checkpoint Inhibitor Therapy
- PMID: 28579959
- PMCID: PMC5450505
- DOI: 10.3389/fphar.2017.00311
Corrigendum: Current Diagnosis and Management of Immune Related Adverse Events (irAEs) Induced by Immune Checkpoint Inhibitor Therapy
Abstract
[This corrects the article on p. 49 in vol. 8, PMID: 28228726.].
Keywords: check point inhibitors; immune related adverse events; ipilimumab; nivoulmab; pembrolizumab.
Erratum for
-
Current Diagnosis and Management of Immune Related Adverse Events (irAEs) Induced by Immune Checkpoint Inhibitor Therapy.Front Pharmacol. 2017 Feb 8;8:49. doi: 10.3389/fphar.2017.00049. eCollection 2017. Front Pharmacol. 2017. PMID: 28228726 Free PMC article. Review.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources